Interleukin-17-dressed neutrophil: Neutrophil does not produce but delivers interleukin-17 to lesional epidermis causing keratinocyte S100A expression Sir 
, Because of the astonishing effect of anti-interleukin (IL)-17
antibody biologics on psoriasis, the importance of IL-17 is obvious in the clinical pathogenesis of psoriasis. IL-17
Figure 1a: mRNA expression levels (∆∆CT value) of cytokeratins and S100As in HaCat cells after co-culture with interleukin-17s (250 ng/mL) and with or without neutrophil-dressed recombinant human interleukin-17A (100, 250, or 500 ng/mL) for 48 hours are shown. S100A7, -8, and -9 mRNA levels in HaCat cells cultured with interleukin-17A-dressed neutrophils were significantly elevated. Keratin 17 and 16 levels were elevated with neutrophil supplementation, but not with interleukin-17A.
Figure 1b: mRNA expression levels (∆∆CT value) of cytokeratins and S100As in HaCat cells after co-culture with interleukin-17s (250 ng/mL) and with or without neutrophil-dressed recombinant human interleukin-17F (100, 250, or 500 ng/mL) for 48 hours are shown. S100A7, -8, and -9 mRNA levels in HaCat cells cultured with interleukin-17F-dressed neutrophils were significantly elevated. Keratin 17 and 16 levels were elevated with neutrophil supplementation, but not with interleukin-17F.
acts on keratinocytes to produce antimicrobial peptides, inflammatory proteins, and proinflammatory cytokines and chemokines including CXCL1 and CXCL8, which recruit neutrophils to the psoriatic lesions. Psoriatic lesions are characterized by epidermal proliferation, parakeratosis and neutrophil infiltration forming subcorneal microabscess. Until recently, neutrophils have been considered as IL-17 producing cells like Th17, γδ T cells, monocytes, NK cells, and type 3 innate lymphoid cells (ILC3) based on the presence of immunoreactive IL-17 on the neutrophils and IL-17 messenger RNA (mRNA) expression. 1 However, we have declared the absence of IL-17 mRNA expression in highly purified neutrophils, and IL-17 mRNAs are derived from contaminated lymphocytes and monocytes in patients with psoriasis. 2 These facts implicate the presence of IL-17-decorated neutrophil, "IL-17-dressed neutrophil," in psoriasis as a transporter of IL-17 to the lesional epidermis.
We here investigated the role of IL-17-dressed neutrophil in especially keratin (K) and S100A mRNA expression using a keratinocyte cell line, HaCat cells. HaCat cells (CLS Cell Lines Service, Eppelheim, Germany) were cultured in Dulbecco's Modified Eagle Medium (DMEM; Nacalai Tesque, Kyoto, Japan) supplemented with 10% fetal bovine serum (FBS; Biosera, Ringmer, UK), 1% l-glutamine (LGL; Nacalai Tesque), and 1% penicillin-streptomycin (P/S; Sigma-Aldrich, St. Louis, MO, USA). The neutrophils were isolated by MACS ® Neutrophil Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) from the venous blood of the healthy volunteers (n = 4). The isolated neutrophils (1.0-3.0 × 10 6 /mL) were cultured in Roswell Park Memorial Institute (RPMI) 1640 (Nacalai Tesque) with 10% FBS, 1% LGL, and 1% P/S with or without recombinant human IL-17A (rhIL-17A; R and D Systems, Minneapolis, MN, USA), rhIL-17F (BioLegend, San Diego, CA, USA), or rhIL-17C (R and D Systems) for 2 hours. After washing twice, the neutrophils were cocultured with 40%-60% of confluent HaCat cells for 48 hours in DMEM/RPMI (1:1). Total RNA was extracted using TRI Reagent ® (Molecular Research Center, Cincinnati, OH, USA), and complementary DNA (cDNA) was synthesized using High-Capacity RNA-to-cDNA™ Kit (Applied Biosystems, Foster City, CA, USA). Quantitative real-time polymerase chain reaction was performed using LightCycler ® 96 System (Roche Diagnostics, Mannheim, Germany) with TaqMan™ Universal Master Mix II, with UNG (Applied Biosystems). Primer sets K10, K16, K17, S100A7, S100A8, S100A9, and beta-actin (ACTB) for internal control were purchased from Applied Biosystems. Upregulation of proliferation-related keratins, K16 and K17, and downregulation of K10 are characteristic in psoriatic epidermis. 3 In this study, HaCat cells treated by neutrophils either with or without IL-17A showed the elevation of K16 or K17 mRNA levels with marginal significance, and there was no obvious change in K10 mRNA expression [ Figure 1a ]. This result suggests that the neutrophil itself activates keratinocytes, but IL-17A does not activate. Elevation of S100A7, -8, and -9 mRNA levels is also characteristic in psoriasis epidermis. Interestingly, S100A7, -8, and -9 mRNA levels in HaCat cells cultured with IL-17A-attached neutrophils were significantly elevated concentration dependently [ Figure 1a ]. Effects of IL-17F-treated neutrophils on keratin mRNA expression of HaCat cells were similar to that of IL-17A [ Figure 1b] . S100A7, -8, and -9 mRNA levels were also elevated significantly with IL-17F-dressed neutrophils [ Figure 1b] . IL-17C showed no additional effects on keratin and S100As' mRNA expression in HaCat cells [ Figure 1c ].
Augmentation of K17 mRNA expression in the cultured keratinocytes by IL-17A has been reported previously; however, its expression was unchanged in HaCat cells in this study. 3 Neutrophil itself triggers the activation of keratinocyte. In contrast, S100A8 and -9 from keratinocytes have important role in neutrophil migration into the inflammatory lesions, and those expressions are significantly upregulated by IL-17A-decorated neutrophil dose dependently. 4 As we reported previously, neutrophils are not the major producers of IL-17A; however, neutrophils are possible transporters of IL-17A. This study declared that IL-17A adhered on to the neutrophils has no obvious effects on keratinocyte activation. However, IL-17A/F and neutrophils showed synergistic effects on S100As' expression in keratinocytes. This suggests that IL-17A/F-dressed neutrophils are functional and may carry IL-17s to the lesional epidermis and enhance neutrophil recruitment inducing keratinocytes S100As. K16 and K17 expressions were increased with the supplementation of neutrophils without IL-17, which suggests direct interaction of neutrophils, and keratinocytes promote keratinocyte activation without IL-17A. Interestingly, IL-17F-but not IL-17C-dressed neutrophils induced S100 expression as well as IL-17A, which suggests IL-17A/F but not IL-17C is a possible therapeutic target for psoriasis and IL-17-mediated diseases. However, the limitation is that we did not reveal the function of dressed neutrophil in vivo. The present results confirmed the biological roles of IL-17-dressed neutrophil and proposed a mechanism for anti-IL-17 therapies in psoriasis in part.
Sir, Psoriasis is characterized by exaggerated and disordered epidermal cell proliferation and keratinization. The impaired epidermal barrier plays a role in the pathogenesis of psoriasis. Tight junctions form a barrier in the granular cell layer of the epidermis and are involved in proliferation, differentiation, cell-cell adhesion, and apoptosis of keratinocytes.
1 Claudin-1 and claudin-7 play crucial roles in the formation of these tight junctions and are associated with its strength, size, and ion specificity. The alteration of the tight junction proteins is an early event in psoriasis, with claudin-1 and claudin-7 being downregulated in the basal and uppermost layers of the epidermis. 2 The expression level of claudin-1 is lower in the psoriatic plaque, compared to the healthy or uninvolved skin.
Interleukin-36 (IL-36) belongs to the IL-1 family of cytokines and includes IL-36α, IL-36β, IL-36γ, and IL-36 receptor antagonist (Ra). All the forms of IL-36 are overexpressed in the psoriatic skin lesion. The hypothesis that the tight junctions and other skin barriers, including the immunological barrier, influence each other, was supported by a variety of experimental data. Watson et al. showed that IL-1β can downregulate the expression of tight junction proteins in the skin. 3 IL-36, a member of the IL-1 family of cytokines, might also influence the expression of these proteins. In this study, IL-36γ was selected in the lesional skin of psoriasis patients, as it is the only IL-36 cytokine constitutively expressed in the skin and may become a potential biomarker of psoriasis. 4 This study detected the expression of IL-36γ and tight junction proteins and revealed their correlation in psoriasis.
A total of 42 patients diagnosed with extensive psoriasis vulgaris, and 15 age-and gender-matched healthy controls, attending the Department of Dermatology of First Affiliated Hospital of Zhejiang University, Hangzhou, China, were included in the study. Skin biopsy was obtained from the lesion and immunohistochemistry was performed on it. None of the patients receive any systemic treatment for 3 months or any topical medication for 2 weeks prior to the biopsy. Patients with any other skin or systemic disorder were excluded. Psoriasis Area and Severity Index score was used to evaluate the severity of the disease.
The age of the included patients ranged from 18 to 79 years, with a median age of 45 years. Clinical data are depicted in Table 1 . IL-36γ was found to be expressed, mainly in the cells of granular and adjacent spinous layers, while
